Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticoagulation in hospitalized patients with COVID-19
Lisa Baumann Kreuziger, Michelle Sholzberg, Mary Cushman
Blood (2022) Vol. 140, Iss. 8, pp. 809-814
Open Access | Times Cited: 19

Showing 19 citing articles:

Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 535-535
Open Access
Severely Ill COVID-19 Patients May Exhibit Hypercoagulability Despite Escalated Anticoagulation
Soslan S. Shakhidzhanov, A. E. Filippova, Elizaveta Bovt, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1966-1966
Open Access
Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism
Mateo Porres‐Aguilar, Rachel Rosovsky, Belinda Rivera‐Lebron, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 11, pp. 2457-2464
Open Access | Times Cited: 25
Efficacy and Safety of Direct Oral Anticoagulants Compared With Heparin for Preventing Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis
Yong Tian, Tao Pan, Xudong Wen, et al.
Clinical and Applied Thrombosis/Hemostasis (2023) Vol. 29
Open Access | Times Cited: 8
Association of longitudinal platelet count trajectory with ICU mortality: A multi-cohort study
Jiajin Chen, Xi Gao, Sipeng Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Anticoagulant therapy in COVID‐19: A narrative review
Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 9, pp. 1510-1525
Open Access | Times Cited: 6
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies
Sonia Elhadad, David Redmond, Adrian Wei-Yee Tan, et al.
Thrombosis Research (2023) Vol. 225, pp. 47-56
Open Access | Times Cited: 4
Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves—a retrospective observational study
Shir Ying Lee, Winnie Z.Y. Teo, Cheryl X.Q. Lim, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 7, pp. 102218-102218
Open Access | Times Cited: 4
COVID-19-associated Coagulopathy Characterization using Rotational Thromboelastometry in a Prospective, Observational Cohort Study: The HemoCoV Study
Anabela Rodrigues, Tiago Dias Domingues, Gustavo Nobre de Jesus, et al.
Acta Médica Portuguesa (2023) Vol. 36, Iss. 7-8, pp. 496-505
Open Access | Times Cited: 2
Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients
Marko Lucijanić, Ida Tješić-Drinković, Nevenka Piskač Živković, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1699-1699
Open Access | Times Cited: 2
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials
Maddalena Alessandra Wu, Cinzia Del Giovane, Riccardo Colombo, et al.
Internal and Emergency Medicine (2023) Vol. 19, Iss. 1, pp. 71-79
Closed Access | Times Cited: 2
Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19
Sahishnu Patel, Alexis Visotcky, Adam Devine, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 10
Open Access
Sars-CoV-2 infection in different hematological patients
Saša Anžej Doma
Elsevier eBooks (2024), pp. 397-407
Closed Access
Nasopharyngeal viral load at admission is not an independent predictor of thromboembolic complications in unvaccinated COVID-19 hospitalized patients.
Narda Ontiveros, Adolfo Del Bosque-Aguirre, Mauricio González-Urquijo, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 55, Iss. 2, pp. 282-288
Open Access | Times Cited: 3
ECMO aggravates platelet GPV shedding and δ-granule deficiency in COVID-19-associated acute respiratory distress syndrome
Johannes Herrmann, Lukas J Weiss, Bastian Just, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 8, pp. 2316-2330
Open Access
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study
Carlos Escobar, Ramón Bover Freire, Xavier García–Moll, et al.
Cardiovascular Diagnosis and Therapy (2023) Vol. 13, Iss. 5, pp. 777-791
Open Access | Times Cited: 1
The intensity of anticoagulant dosing in hospitalized patients with COVID‐19: An observational, comparative effectiveness study
Laura C. Myers, Stanley Xu, Aiyu Chen, et al.
Journal of Hospital Medicine (2022) Vol. 18, Iss. 1, pp. 43-54
Open Access | Times Cited: 2
What's New in Critical Illness and Injury Science? Alteplase for severe coronavirus disease 2019
Sathya Areti, M Mäki, Kenneth E. Remy
International Journal of Critical Illness and Injury Science (2022) Vol. 12, Iss. 4, pp. 181-183
Open Access
Page 1

Scroll to top